Market comparison
Which peptides will the FDA propose adding to the 503A Bulks List?
1 venue · 7 outcome rows · 0 comparable lines · 0 verified parity · active
Kalshi
Open venue ↗7 outcomes · $2K reported volume
Observed 54s ago
Recorded venue end date: Oct 1, 2027
No shared outcome identities or comparable outcome lines are available for this event. Each venue’s outcomes are listed separately.
| Outcome | Kalshi | Difference |
|---|---|---|
BPC-157 Not alignedNo persisted outcome identity connects these venue contracts. | — | |
Emideltide Not alignedNo persisted outcome identity connects these venue contracts. | — | |
Epitalon Not alignedNo persisted outcome identity connects these venue contracts. | — | |
KPV Not alignedNo persisted outcome identity connects these venue contracts. | — | |
MOTS-c Not alignedNo persisted outcome identity connects these venue contracts. | — | |
Semax Not alignedNo persisted outcome identity connects these venue contracts. | — | |
TB-500 Not alignedNo persisted outcome identity connects these venue contracts. | — |
BPC-157
Not alignedNo persisted outcome identity connects these venue contracts.
Kalshi
Emideltide
Not alignedNo persisted outcome identity connects these venue contracts.
Kalshi
Epitalon
Not alignedNo persisted outcome identity connects these venue contracts.
Kalshi
KPV
Not alignedNo persisted outcome identity connects these venue contracts.
Kalshi
MOTS-c
Not alignedNo persisted outcome identity connects these venue contracts.
Kalshi
Semax
Not alignedNo persisted outcome identity connects these venue contracts.
Kalshi
TB-500
Not alignedNo persisted outcome identity connects these venue contracts.
Kalshi
Prices are shown as percentages of a $1 payout. “pp” means percentage points. A dash means data is unavailable.